Cargando…

Angiotensin Receptor Blockers Decrease the Risk of Major Adverse Cardiovascular Events in Patients with End-Stage Renal Disease on Maintenance Dialysis: A Nationwide Matched-Cohort Study

BACKGROUND: Major adverse cardiovascular events (MACE) cause the leading cause of morbidity and mortality in patients with end-stage renal disease (ESRD) on maintenance Hemodialysis (HD) or peritoneal dialysis (PD). Many randomized-controlled trials (RCTs) have proved that angiotensin receptor block...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Chung-Wei, Tzeng, Nian-Sheng, Yin, Yun-Ju, Li, Chien-Hsun, Chen, Hung-An, Chiu, Shih-Hsiang, Ho, Shinn-Ying, Huang, Hui-Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619342/ https://www.ncbi.nlm.nih.gov/pubmed/26488749 http://dx.doi.org/10.1371/journal.pone.0140633

Ejemplares similares

Association of Renin-Angiotensin System Blockers with Survival in Patients on Maintenance Hemodialysis
por: Kang, Seok Hui, et al.
Publicado: (2023)

Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Terms of Major Cardiovascular Disease Outcomes in Elderly Patients: A Nationwide Population-Based Cohort Study
por: Chien, Shu-Chen, et al.
Publicado: (2015)

Renal Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Liver Cirrhosis: A Nationwide Cohort Study
por: Hsu, Wei-Fan, et al.
Publicado: (2019)

Different angiotensin receptor blockers and incidence of diabetes: a nationwide population-based cohort study
por: Chang, Chia-Hsuin, et al.
Publicado: (2014)

Angiotensin II receptor blockers and oral squamous cell carcinoma survival: A propensity-score-matched cohort study
por: Wu, Ching-Nung, et al.
Publicado: (2021)

Does a Supplemental Low-Protein Diet Decrease Mortality and Adverse Events After Commencing Dialysis? A Nationwide Cohort Study
por: Yen, Chieh-Li, et al.
Publicado: (2018)

Angiotensin-Receptor Blocker, Angiotensin-Converting Enzyme Inhibitor, and Risks of Atrial Fibrillation: A Nationwide Cohort Study
por: Hsieh, Yu-Cheng, et al.
Publicado: (2016)

Angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers and hemorrhoids: A nationwide, population-based study
por: Hu, Wei-Syun, et al.
Publicado: (2023)

Effect of angiotensin receptor blockers on the development of cancer: A nationwide cohort study in korea
por: Jung, Mi‐Hyang, et al.
Publicado: (2021)

The Combination of Beta Blockers and Renin-Angiotensin System Blockers Improves Survival in Incident Hemodialysis Patients: A Propensity-Matched Study
por: Luño, José, et al.
Publicado: (2017)

Association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysis
por: Shah, Mitesh, et al.
Publicado: (2014)

Association Between Antibiotic Treatment of Chlamydia pneumoniae and Reduced Risk of Alzheimer Dementia: A Nationwide Cohort Study in Taiwan
por: Ou, Hsun, et al.
Publicado: (2021)

Is schizophrenia associated with an increased risk of chronic kidney disease? A nationwide matched-cohort study
por: Tzeng, Nian-Sheng, et al.
Publicado: (2015)

Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: Effectiveness in combination with diuretics or β-blockers for treating hypertension
por: Bisognano, John D, et al.
Publicado: (2007)

ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients
por: Daoud, Ahmed, et al.
Publicado: (2021)

Angiotensin receptor blocker add-on therapy in portal hypertension: To use angiotensin receptor blocker or not to use, that is the question
por: Lee, Hyun Woong
Publicado: (2014)

Depression amongst patients commencing maintenance dialysis is associated with increased risk of death and severe infections: A nationwide cohort study
por: Wu, Ping-Hsun, et al.
Publicado: (2019)

Angiotensin Converting-Enzyme Inhibitors, Angiotensin Receptor Blockers, and Calcium Channel Blockers Are Associated with Prolonged Vascular Access Patency in Uremic Patients Undergoing Hemodialysis
por: Chen, Fu-An, et al.
Publicado: (2016)

Psychiatric disorders in female psychosexual disorders—a nationwide, cohort study in Taiwan: Psychiatric disorders and female psychosexual disorders
por: Lin, Iau-Jin, et al.
Publicado: (2021)

Rheumatoid Arthritis Associated with Dry Eye Disease and Corneal Surface Damage: A Nationwide Matched Cohort Study
por: Lai, Shih-Chung, et al.
Publicado: (2023)

Angiotensin Receptor Blocker Associated with a Decreased Risk of Lung Cancer: An Updated Meta-Analysis
por: Wang, Zexu, et al.
Publicado: (2023)

Effects of calcium channel blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis
por: Lin, Yen-Chung, et al.
Publicado: (2017)

Renin–Angiotensin System Blockers and Adverse Outcomes of Influenza and Pneumonia: A Danish Cohort Study
por: Christiansen, Christian Fynbo, et al.
Publicado: (2020)

Angiotensin receptor blockers and COVID-19
por: Saavedra, Juan M.
Publicado: (2020)

Angiotensin receptor blocker neprilysin inhibitors
por: Usuda, Daisuke, et al.
Publicado: (2021)

Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
por: Danser, A.H. Jan, et al.
Publicado: (2020)

Renin-angiotensin system blockers and residual kidney function loss in patients initiating peritoneal dialysis: an observational cohort study
por: Shen, Jenny I., et al.
Publicado: (2017)

Effect of anti-diabetic drugs in dialysis patients with diabetes: a nationwide retrospective cohort study
por: Ou, Shih-Hsiang, et al.
Publicado: (2021)

The Usage of Histamine Type 1 Receptor Antagonist and Risk of Dementia in the Elderly: A Nationwide Cohort Study
por: Yang, Chuan-Chi, et al.
Publicado: (2022)

Premorbid Use of Beta-Blockers or Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Patients with Acute Ischemic Stroke
por: Zeng, Yuanyuan, et al.
Publicado: (2023)

Examining the correlation between diabetes and odontogenic infection: A nationwide, retrospective, matched-cohort study in Taiwan
por: Ko, Hui-Hsin, et al.
Publicado: (2017)

Effects of Angiotensin Converting Enzyme Inhibition or Angiotensin Receptor Blockade in Dialysis Patients: A Nationwide Data Survey and Propensity Analysis
por: Wu, Cho-Kai, et al.
Publicado: (2015)

Initial Angiotensin Receptor Blocker Response in Young Marfan Patients Decreases After 3 Years of Treatment
por: Pees, Christiane, et al.
Publicado: (2021)

Posttraumatic stress disorder and the risk of erectile dysfunction: a nationwide cohort study in Taiwan: PTSD and erectile dysfunction
por: Wang, Sheng-Chiang, et al.
Publicado: (2021)

Association between amphetamine‐related disorders and dementia‐a nationwide cohort study in Taiwan
por: Tzeng, Nian‐Sheng, et al.
Publicado: (2020)

Impact of drug price adjustments on utilization of and expenditures on angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in Taiwan
por: Huang, Shiou-Huei, et al.
Publicado: (2012)

Use of Antihypertensive Agents and Association With Risk of Adverse Outcomes in Chronic Kidney Disease: Focus on Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Ku, Elaine, et al.
Publicado: (2018)

A propensity score‐matching analysis of angiotensin‐converting enzyme inhibitor and angiotensin receptor blocker exposure on in‐hospital mortality in patients with acute respiratory failure
por: Fang, Yi‐Peng, et al.
Publicado: (2022)

Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events and residual renal function in dialysis patients: a meta-analysis of randomised controlled trials
por: Liu, Youxia, et al.
Publicado: (2017)

Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
por: Ho, Cheng-Maw, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_42dea4i6boede326mvg37q1hcf